EUVIMEDEUVIMED entdecken
Crossref

Investigation of the anti-microbial and anti-inflammatory properties of Weizmannia coagulans MBBCM9™ and formulation of a probiotic oral health product

Tanvi Sawant, Pankti Ganatra, Pooja Sawant, Ameya Parkar, Mruduka Patel, Nikunj Patel, Gaurav Kaushik, Prajakta Dandekar, Ratnesh Jain

World Journal of Microbiology and Biotechnology · 2026

DOI: 10.1007/s11274-026-05134-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2026. Verfasst von Tanvi Sawant und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India. Hauptthemen laut MEDLINE: Probiotics, Anti-Inflammatory Agents, Anti-Infective Agents. Die Arbeit nennt 172 Literaturangaben. Gefördert von: Meteoric Biopharmaceuticals, Institute of Chemical Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotics with anti-microbial and anti-inflammatory activity can help manage caries, plaque, and gingivitis. Routine oral-care products can serve as effective delivery vehicles for probiotic administration, and spore-forming probiotics are well suited for this application because they can survive, germinate, and provide sustained benefits. A spore-forming probiotic Weizmannia coagulans MBBCM9™ was selected for the study that demonstrated partial germination (28.70 ± 0.77%) in artificial saliva under in-vitro conditions within 2 h, as indicated by a reduction in OD600, while exhibiting less than 1 - log reduction in viability in the presence of herbal extracts, supporting its potential application in probiotic herbal oral-care formulations. Subsequently, the anti-microbial and anti-inflammatory properties of MBBCM9™ were evaluated. MBBCM9™ showed anti-microbial activity against Streptococcus mutans, with an inhibition zone of 11.33 ± 0.58 mm in an agar diffusion assay and a 46.18 ± 0.42% reduction in biofilm formation, as determined by in-vitro assays. It also significantly reduced inflammation in IL-1β induced primary gingival fibroblasts (PGF) in-vitro, with 16.01 ± 5.9% and 11.43 ± 3.13% reduction in IL-6 and IL-8 cytokine levels. We formulated a toothpaste with MBBCM9™ spore powder and herbal extracts having anti-inflammatory and anti-microbial properties, using suitable excipients. The formulation demonstrated desired viscoelasticity, hardness, adhesiveness, alkaline pH (8.31 ± 0.02), low water activity (0.73 ± 0.002), along with good abrasiveness, spreadability (6.06 ± 0.06 cm), and foaming capacity (56 ± 1.73 cm) and it enhanced viability of PGF cells in-vitro. Stability testing demonstrated maintenance of spore viability in the toothpaste matrix for up to 12 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsAnti-Inflammatory AgentsAnti-Infective AgentsStreptococcus mutansHumansBiofilmsFibroblastsGingivaPlant ExtractsSaliva, ArtificialMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Weizmannia coagulans MBBCM9™Probiotic dentifriceanti-biofilmanti-inflammatoryanti-microbialformulationphysicochemical testsprobiotic stability

Substanzen

Anti-Inflammatory AgentsPlant ExtractsAnti-Infective AgentsSaliva, Artificial

Autor:innen und Institutionen

  • Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
  • Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
  • Meteoric Biopharmaceuticals PVT LTD, Ahmedabad, 380015, Gujarat, India.
  • Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India. pd.jain@ictmumbai.edu.in.
  • Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India. rd.jain@ictmumbai.edu.in.

Förderung

  • Meteoric Biopharmaceuticals
  • Institute of Chemical Technology

Zitieren

APA

Sawant, T., Ganatra, P., Sawant, P., Parkar, A., Patel, M., Patel, N., Kaushik, G., Dandekar, P., & Jain, R. (2026). Investigation of the anti-microbial and anti-inflammatory properties of Weizmannia coagulans MBBCM9™ and formulation of a probiotic oral health product. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-026-05134-2

Vancouver

Sawant T, Ganatra P, Sawant P, Parkar A, Patel M, Patel N, et al. Investigation of the anti-microbial and anti-inflammatory properties of Weizmannia coagulans MBBCM9™ and formulation of a probiotic oral health product. World Journal of Microbiology and Biotechnology. 2026. doi:10.1007/s11274-026-05134-2

BibTeX
@article{Sawant2026,
  author = {Sawant, Tanvi and Ganatra, Pankti and Sawant, Pooja and Parkar, Ameya and Patel, Mruduka and Patel, Nikunj and Kaushik, Gaurav and Dandekar, Prajakta and Jain, Ratnesh},
  title = {Investigation of the anti-microbial and anti-inflammatory properties of Weizmannia coagulans MBBCM9™ and formulation of a probiotic oral health product},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2026},
  doi = {10.1007/s11274-026-05134-2}
}
Kostenlos starten →